Skip to main content
Investor directorySource attributed
The Column Group

Venture Fund · San Francisco

Fund description

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Stages and sectors

Pre-SeedSeedSeries ASeries BSeries CSeries DHealthcareLife Science

Portfolio companies

Hexagon BioAccent TherapeuticsCasma TherapeuticsA2 BiotherapeuticsRibon Therapeutics
Contact and links

Partner

Peter Svennilson

Location

San Francisco

Founded

2006

About this listing

Source

Investor directory

Created

6/20/2026

Always verify investor fit and contact information before outreach.